175 related articles for article (PubMed ID: 2239570)
41. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
LeFrock JL; Smith BR; Chandrasekar P; Rolston KV; Molavi A; Kannangara W
Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751
[TBL] [Abstract][Full Text] [Related]
42. Aztreonam in the treatment of serious gram-negative infections in the elderly.
Deger F; Douchamps J; Freschi E; Thys JP; Nève P; Herchuelz A
Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):22-6. PubMed ID: 3403089
[TBL] [Abstract][Full Text] [Related]
43. [Comparative studies of DL-8280 and pipemidic acid in complicated urinary tract infections by double-blind method].
Kishi H; Nito H; Saito I; Nishimura Y; Niijima T; Ohmori H; Tanaka H; Fujita Y; Deguchi K; Ogawa N
Hinyokika Kiyo; 1984 Sep; 30(9):1307-55. PubMed ID: 6395684
[TBL] [Abstract][Full Text] [Related]
44. [Concomitant therapy with cefmenoxime and cefsulodin for refractory complicated urinary tract infection (especially caused by Pseudomonas aeruginosa)].
Ishigami J; Fujii A; Harada M; Arakawa S; Umezu K; Kawabata G; Kataoka N; Kamidono S; Miyazaki S; Takasaki N
Hinyokika Kiyo; 1986 May; 32(5):779-88. PubMed ID: 3463188
[TBL] [Abstract][Full Text] [Related]
45. [Bacterial combination effect between carumonam and eight other antibiotics].
Obana Y; Murakami T; Kuzui H; Nishino T
Jpn J Antibiot; 1990 Dec; 43(12):2094-101. PubMed ID: 2128341
[TBL] [Abstract][Full Text] [Related]
46. [Clinical studies and morphological response on ST-95 (fosfomycin)].
Washida H; Watanabe H; Noguchi Y; Kato M; Tozawa K; Inuzuka K
Hinyokika Kiyo; 1991 Mar; 37(3):321-6. PubMed ID: 2069116
[TBL] [Abstract][Full Text] [Related]
47. [Well-controlled comparative study on aztreonam and cefoperazone in the treatment of complicated urinary tract infections].
Ohmori H; Kumon H; Kumamoto Y; Sakai S; Niijima T; Kishi H; Ohkoshi M; Kawamura N; Naide Y; Nishiura T
Jpn J Antibiot; 1986 Jan; 39(1):24-56. PubMed ID: 3517407
[TBL] [Abstract][Full Text] [Related]
48. [The effectiveness of enoxacin for the treatment of complicated urinary tract infection].
Germinario C; Quarto M; Viggiani N; Schena FP
Riv Eur Sci Med Farmacol; 1992; 14(5):347-51. PubMed ID: 1308966
[TBL] [Abstract][Full Text] [Related]
49. [Clinical experience with cefixime in urinary tract infections].
Kameoka H; Takano Y; Miyoshi S; Iwao N; Mizutani S
Jpn J Antibiot; 1989 Dec; 42(12):2540-7. PubMed ID: 2614911
[TBL] [Abstract][Full Text] [Related]
50. [Clinical studies on tosufloxacin (TFLX) in urology].
Fukushima S; Moriyama M; Miyamoto H; Hosaka M; Kubota Y; Kinoshita Y; Noguchi K; Shuin T; Noguchi S; Yoshimura S
Hinyokika Kiyo; 1992 Apr; 38(4):501-6. PubMed ID: 1529827
[TBL] [Abstract][Full Text] [Related]
51. [Clinical experience with T-2588 in complicated urinary tract infections].
Fukatsu H; Nonomura H; Ohshita H; Miyagawa Y; Hatano Y; Waki M; Takamura T; Hiraiwa S; Yamada Y; Muramatsu T
Hinyokika Kiyo; 1986 Jul; 32(7):1061-8. PubMed ID: 3776768
[TBL] [Abstract][Full Text] [Related]
52. Fosfomycin: an old--new antibiotic.
Raz R
Clin Microbiol Infect; 2012 Jan; 18(1):4-7. PubMed ID: 21914036
[TBL] [Abstract][Full Text] [Related]
53. [Prophylaxis in prostatic surgery with aztreonam. Our experience].
Moyano Calvo JL; Arellano Gañán R; Sempere Gutiérrez A; Sanz Sacristán J; Teba del Pino F; Melón Rey FJ; Herrero Torres L; Pereira Sanz I
Arch Esp Urol; 1992; 45(6):519-21. PubMed ID: 1510489
[TBL] [Abstract][Full Text] [Related]
54. [Clinical study of carumonam].
Takebe K; Tamura T; Endo K; Irie T; Sekino K; Uehara O; Sagara M; Okamoto K
Jpn J Antibiot; 1987 Nov; 40(11):1917-22. PubMed ID: 3444030
[TBL] [Abstract][Full Text] [Related]
55. [Effect of combination therapy with carumonam and clindamycin on severe infections in patients with hematologic malignancies].
Shimazaki C; Inaba T; Murakami S; Oku N; Itoh K; Ura Y; Nakagawa M; Fujita N
Jpn J Antibiot; 1990 Aug; 43(8):1402-6. PubMed ID: 2283708
[TBL] [Abstract][Full Text] [Related]
56. Oral and intravenous fosfomycin in complicated urinary tract infections.
López-Montesinos I; Horcajada JP
Rev Esp Quimioter; 2019 May; 32 Suppl 1(Suppl 1):37-44. PubMed ID: 31131591
[TBL] [Abstract][Full Text] [Related]
57. [Clinical experience with ceftibuten in complicated urinary tract infections].
Mizutani S; Nishimura K; Yoshimura K; Miyoshi S; Iwao N; Higashimoto J; Shiota K
Jpn J Antibiot; 1990 May; 43(5):779-89. PubMed ID: 2391749
[TBL] [Abstract][Full Text] [Related]
58. Carumonam versus ceftazidime for urinary tract infections.
Edelstein H; Oster S; Cassano K; McCabe R
Antimicrob Agents Chemother; 1988 Jul; 32(7):1031-3. PubMed ID: 3056245
[TBL] [Abstract][Full Text] [Related]
59. [Fosfomycin in the treatment of some infectious diseases].
Aceti A; Vullo V; Ferone U; Delia S
Clin Ter; 1979 Jan; 88(1):61-6. PubMed ID: 436378
[No Abstract] [Full Text] [Related]
60. Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis.
Seroy JT; Grim SA; Reid GE; Wellington T; Clark NM
J Antimicrob Chemother; 2016 Sep; 71(9):2563-8. PubMed ID: 27246234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
